<DOC>
	<DOCNO>NCT01341782</DOCNO>
	<brief_summary>This study comparison efficacy safety paricalcitol injection maxacalcitol injection adult Japanese chronic kidney disease patient receive hemodialysis secondary hyperparathyroidism . The main objective study demonstrate efficacy paricalcitol injection reduce level parathyroid hormone without clinically significant hypercalcemia , compare maxacalcitol injection .</brief_summary>
	<brief_title>Comparison Efficacy Safety Paricalcitol Injection With Maxacalcitol Injection Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Maxacalcitol</mesh_term>
	<criteria>Adult Chronic Kidney Disease ( CKD ) Stage 5 patient undergoing dialysis stable dialysate calcium phosphate binder On three time weekly hemodialysis least 3 month prior intact parathyroid hormone ( iPTH ) great equal 300 pg/mL , adjust normalized serum total calcium ( Ca ) great equal 8.4 less 10.2 mg/dL , serum phosphorus ( P ) less equal 6.5 mg/dL . Patients recent history severe cardiovascular hepatic disease , uncontrolled hypertension uncontrolled diabetes Patients receive parathyroidectomy ethanol infusion within prior year Patients take drug affect iPTH , calcium bone metabolism Patients need take chronic dos ( great equal 2 consecutive week ) cytochrome P450 inhibitor ( e.g. , clarithromycin , grapefruit product ) inducer ( e.g. , carbamazepine , rifampicin ) Female patient pregnant , possibly pregnant , wish become pregnant , participate breastfeed study period .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Secondary hyperparathyroidism</keyword>
	<keyword>Paricalcitol</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Maxacalcitol</keyword>
</DOC>